Publicacións en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (26)

2024

  1. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  2. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  3. Nutritional and Morphofunctional Assessment of Post-ICU Patients with COVID-19 at Hospital Discharge: NutriEcoMuscle Study

    Nutrients, Vol. 16, Núm. 6

  4. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Expert Consensus on Morphofunctional Assessment in Disease-Related Malnutrition. Grade Review and Delphi Study

    Nutrients, Vol. 15, Núm. 3

2022

  1. Aetiological diagnosis of hyponatraemia in non-critical patients on total parenteral nutrition: A prospective multicentre study

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 3, pp. 160-167

  2. Multidisciplinary consensus on nutritional and metabolic therapy in enhanced recovery after abdominal surgery programs: NutRICA Project

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 2, pp. 98-111

  3. Reducing stigma-discrimination. Help seeking-empowerment. Emotional education-mental health literacy

    Nutricion Hospitalaria, Vol. 39, Núm. Ext2, pp. 49-54

  4. Self-esteem, self-image, and school bullying in eating disorders

    Nutricion Hospitalaria, Vol. 39, Núm. Ext2, pp. 41-48

2021

  1. A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

    Journal of Clinical Investigation, Vol. 131, Núm. 20

2020

  1. Fish oil enriched intravenous lipid emulsions reduce triglyceride levels in non-critically ill patients with TPN and type 2 diabetes. a post-hoc analysis of the INSUPAR study

    Nutrients, Vol. 12, Núm. 6

  2. Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 10, pp. 828-834

  3. Regular insulin added to total parenteral nutrition vs subcutaneous glargine in non-critically ill diabetic inpatients, a multicenter randomized clinical trial: INSUPAR trial

    Clinical Nutrition, Vol. 39, Núm. 2, pp. 388-394

  4. Risk factors for hypoglycemia in inpatients with total parenteral nutrition and type 2 diabetes: A post hoc analysis of the InSUPAR study

    Endocrine Practice, Vol. 26, Núm. 6, pp. 604-611

2019

  1. ANGPTL-4 is associated with obesity and lipid profile in children and adolescents

    Nutrients, Vol. 11, Núm. 6

2018

  1. Terms, concepts and definitions in clinical artificial nutrition. The ConT-SEEN Project

    Endocrinologia, Diabetes y Nutricion, Vol. 65, Núm. 1, pp. 5-16

2017

  1. Prevalence of acromegaly in patients with symptoms of sleep apnea

    PLoS ONE, Vol. 12, Núm. 9

2015

  1. Hypoglycemia in noncritically ill patients receiving total parenteral nutrition: A multicenter study. (Study group on the problem of hyperglycemia in parenteral nutrition; Nutrition area of the Spanish Society of Endocrinology and Nutrition)

    Nutrition, Vol. 31, Núm. 1, pp. 58-63

  2. Nutrition-related risk indexes and long-term mortality in noncritically ill inpatients who receive total parenteral nutrition (prospective multicenter study)

    Clinical Nutrition, Vol. 34, Núm. 5, pp. 962-967

  3. Prevalence of diabetes, prediabetes, and stress hyperglycemia: Insulin therapy and metabolic control in patients on total parenteral nutrition (prospective multicenter study)

    Endocrine Practice, Vol. 21, Núm. 1, pp. 59-67